Objective: To compare the 24-hour sustained efficacy and safety of a new tramadol once-daily formulation (tramadol OAD) using Contramid ® controlled-release technology with a marketed twice-daily ...

This study showed that a multiple-units SR formulation (capsule) produced smoother tramadol plasma concentration profiles than a single-unit SR formulation (tablet), whilst maintaining equivalent ...